Studies: One Dose of "Psilocybin" from Magic Mushrooms Relieves Depression in 80% of Cancer Patients
New studies from NYU and John Hopkins University show the effectiveness of psilocybin in treating depression and anxiety of cancer patients.
The largest studies to date, by arguably the most respected institutions up to this point, show that psilocybin, a compound within "magic mushrooms", can be effective in treating depression and anxiety in cancer patients.
The studies were carried out on 29 patients by researchers at New York University (NYU) and on 51 patients at Johns Hopkins University.
Notably, up to 40% of all cancer patients are afflicted by psychological issues related to their illness.
Around 80% of the cancer patients in the studies got noticeably better after just one dose. And they sustained the psychological gains they made for up to seven months, with few minor side effects. Patients reported improvements in their quality of life, having more energy, going out more and having better relationships with family members.
Interestingly, those who had a stronger trip reported the strongest gains in alleviating their depression and anxiety.
A number of authorities in psychiatry and addiction medicine expressed their support for the work. These include Dr. Jeffrey Lieberman, a former president of the American Psychiatric Association and Dr. Daniel Shalev from the New York State Psychiatric Institute, who wrote that the studies are ”a model for revisiting criminalized compounds of interest in a safe, ethical way.”
The studies were also reviewed by regulators and were described by the New York Times as "most meticulous" to date.
The lead author of the Johns Hopkins study, psychiatrist Dr. Roland Griffiths, was optimistic on the possibilities of the new treatment, likening it to a groundbreaking surgery rather than the painstaking work to make feel people better used by traditional psychiatric approaches.
“I really don’t think we have any models in psychiatry that look like” the effects demonstrated in the two trials, said Griffiths. “Something occurs and it’s repaired and it’s better going forward … very plausibly for more than six months,” he added. “In that sense it’s a new model.”
One of the participants in the study, Sherry Marcy, described the changes in how she felt this way:
"The cloud of doom seemed to just lift… I got back in touch with my family and kids, and my wonder at life," said Marcy, whose been battling cancer from 2010. "Before, I was sitting alone at home, and I couldn't move … This study made a huge difference, and it's persisted."
Psilocybin-containing "magic mushrooms". Credit: Getty Images.
The particulars of both studies involved randomly offering patients either psilocybin or a placebo at the first session, and then giving them the opposite treatment seven weeks later. This way all participants eventually took psilocybin. In both studies, the success rate of psilocybin versus the placebo was very clear, with 83% getting better on psilocybin and only 14% on the placebo in the NYU study.
Psilocybin, of course, have been banned in the U.S. for over 40 years. While they were allowed to use it for their studies, the scientists warn against self-medicating depression by taking "magic mushrooms". They caution that professionals are needed to control the dosage and provide a supportive environment in which to experience the drug's effects. The psilocybin therapy may also not be appropriate for people with schizophrenia or young adults.
To move forward in this field, Dr. Shalev and Dr. Lieberman see a need to loosen research restrictions, because "there is much potential for new scientific insights and clinical applications.” Ideally, the next step would be a trial with a larger sample, perhaps across several centers with hundreds of subjects.
Not everyone is on board. Dr. William Breitbart, chairman of the psychiatry department at the Memorial Sloan-Kettering Cancer Center expressed his reservations about the use of cancer patients for the study.
“Medical marijuana got its foot in the door by making the appeal that ‘cancer patients are suffering, they’re near death, so for compassionate purposes, let’s make it available,’ ” he said. “And then you’re able to extend this drug to other purposes.”
The positive effect of psilocybin on depression was also demonstrated by studies earlier this year.
Cover photo credit: Langone Medical Center/New York University.
Dominique Crenn, the only female chef in America with three Michelin stars, joins Big Think Live this Thursday at 1pm ET.
Scientists discover the inner workings of an effect that will lead to a new generation of devices.
- Researchers discover a method of extracting previously unavailable information from superconductors.
- The study builds on a 19th-century discovery by physicist Edward Hall.
- The research promises to lead to a new generation of semiconductor materials and devices.
Credit: Gunawan/Nature magazine
The number of people with dementia is expected to triple by 2060.
The images and our best computer models don't agree.
A trio of intriguing galaxy clusters<img type="lazy-image" data-runner-src="https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yNDQzNDA0OS9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTYxNTkzNzUyOH0.0IRzkzvKsmPEHV-v1dqM1JIPhgE2W-UHx0COuB0qQnA/img.jpg?width=980" id="d69be" class="rm-shortcode" data-rm-shortcode-id="2d2664d9174369e0a06540cb3a3a9079" data-rm-shortcode-name="rebelmouse-image" />
The three galaxy clusters imaged for the study
Mapping dark matter<span style="display:block;position:relative;padding-top:56.25%;" class="rm-shortcode" data-rm-shortcode-id="d904b585c806752f261e1215014691a6"><iframe type="lazy-iframe" data-runner-src="https://www.youtube.com/embed/fO0jO_a9uLA?rel=0" width="100%" height="auto" frameborder="0" scrolling="no" style="position:absolute;top:0;left:0;width:100%;height:100%;"></iframe></span><p>The assumption has been that the greater the lensing effect, the higher the concentration of dark matter.</p><p>As scientists analyzed the clusters' large-scale lensing — the massive arc and elongation visual effects produced by dark matter — they noticed areas of smaller-scale lensing within that larger distortion. The scientists interpret these as concentrations of dark matter within individual galaxies inside the clusters.</p><p>The researchers used spectrographic data from the VLT to determine the mass of these smaller lenses. <a href="https://www.oas.inaf.it/en/user/pietro.bergamini/" target="_blank" rel="noopener noreferrer">Pietro Bergamini</a> of the INAF-Observatory of Astrophysics and Space Science in Bologna, Italy explains, "The speed of the stars gave us an estimate of each individual galaxy's mass, including the amount of dark matter." The leader of the spectrographic aspect of the study was <a href="http://docente.unife.it/docenti-en/piero.rosati1/curriculum?set_language=en" target="_blank">Piero Rosati</a> of the Università degli Studi di Ferrara, Italy who recalls, "the data from Hubble and the VLT provided excellent synergy. We were able to associate the galaxies with each cluster and estimate their distances." </p><p>This work allowed the team to develop a thoroughly calibrated, high-resolution map of dark matter concentrations throughout the three clusters.</p>
But the models say...<p>However, when the researchers compared their map to the concentrations of dark matter computer models predicted for galaxies bearing the same general characteristics, something was <em>way</em> off. Some small-scale areas of the map had 10 times the amount of lensing — and presumably 10 times the amount of dark matter — than the model predicted.</p><p>"The results of these analyses further demonstrate how observations and numerical simulations go hand in hand," notes one team member, <a href="https://nena12276.wixsite.com/elenarasia" target="_blank">Elena Rasia</a> of the INAF-Astronomical Observatory of Trieste, Italy. Another, <a href="http://adlibitum.oats.inaf.it/borgani/" target="_blank" rel="noopener noreferrer">Stefano Borgani</a> of the Università degli Studi di Trieste, Italy, adds that "with advanced cosmological simulations, we can match the quality of observations analyzed in our paper, permitting detailed comparisons like never before."</p><p>"We have done a lot of testing of the data in this study," Meneghetti says, "and we are sure that this mismatch indicates that some physical ingredient is missing either from the simulations or from our understanding of the nature of dark matter." <a href="https://physics.yale.edu/people/priyamvada-natarajan" target="_blank">Priyamvada Natarajan</a> of Yale University in Connecticut agrees: "There's a feature of the real Universe that we are simply not capturing in our current theoretical models."</p><p>Given that any theory in science lasts only until a better one comes along, Natarajan views the discrepancy as an opportunity, saying, "this could signal a gap in our current understanding of the nature of dark matter and its properties, as these exquisite data have permitted us to probe the detailed distribution of dark matter on the smallest scales."</p><p>At this point, it's unclear exactly what the conflict signifies. Do these smaller areas have unexpectedly high concentrations of dark matter? Or can dark matter, under certain currently unknown conditions, produce a tenfold increase in lensing beyond what we've been expecting, breaking the assumption that more lensing means more dark matter?</p><p>Obviously, the scientific community has barely begun to understand this mystery.</p>
Scientists have found evidence of hot springs near sites where ancient hominids settled, long before the control of fire.